Journey Medical
DERM
36 hedge funds and large institutions have $8.63M invested in Journey Medical in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 4 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 2
375% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 4
71% more funds holding
Funds holding: 21 → 36 (+15)
47% more capital invested
Capital invested by funds: $5.85M → $8.63M (+$2.78M)
5.49% less ownership
Funds ownership: 17.11% → 11.62% (-5.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.07M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$492K |
| 3 |
Neuberger Berman Group
New York
|
+$349K |
| 4 |
Millennium Management
New York
|
+$270K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$253K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.58M |
| 2 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$1.18M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$955K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$856K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$8.91K |
DERM Hedge Fund Activity: Q4 2023 in Review
36 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q4 2023, worth a combined $8.63M — up 47% from $5.85M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new DERM positions and 4 closed out — a net gain of 15 holders — while 12 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.07M. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.58M sold.
- 36 institutional investors held Journey Medical (DERM) as of Q4 2023, up from 21 in Q3 2023.
- Funds reported $8.63M of Journey Medical stock for Q4 2023, up 47% quarter-over-quarter.
- 19 funds opened new Journey Medical positions in Q4 2023 and 4 closed out, a net change of +15 holders.
- The largest Journey Medical buyer in Q4 2023 was Renaissance Technologies, an estimated $1.07M added.
- The largest Journey Medical seller in Q4 2023 was Tang Capital Management, an estimated $1.58M sold.
Based on aggregated 13F filings for Q4 2023.